148 related articles for article (PubMed ID: 10600541)
1. Mechanism of aminobisphosphonate action: characterization of alendronate inhibition of the isoprenoid pathway.
Keller RK; Fliesler SJ
Biochem Biophys Res Commun; 1999 Dec; 266(2):560-3. PubMed ID: 10600541
[TBL] [Abstract][Full Text] [Related]
2. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cis-prenyltransferase reaction probed by substrate analogues.
Lu YP; Liu HG; Teng KH; Liang PH
Biochem Biophys Res Commun; 2010 Oct; 400(4):758-62. PubMed ID: 20828539
[TBL] [Abstract][Full Text] [Related]
4. Rubber elongation by farnesyl pyrophosphate synthases involves a novel switch in enzyme stereospecificity.
Light DR; Lazarus RA; Dennis MS
J Biol Chem; 1989 Nov; 264(31):18598-607. PubMed ID: 2808389
[TBL] [Abstract][Full Text] [Related]
5. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway.
Wang C; Yoon SH; Shah AA; Chung YR; Kim JY; Choi ES; Keasling JD; Kim SW
Biotechnol Bioeng; 2010 Oct; 107(3):421-9. PubMed ID: 20552672
[TBL] [Abstract][Full Text] [Related]
6. Squalene synthase inhibition alters metabolism of nonsterols in rat liver.
Keller RK
Biochim Biophys Acta; 1996 Oct; 1303(3):169-79. PubMed ID: 8908150
[TBL] [Abstract][Full Text] [Related]
7. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates.
van Beek E; Pieterman E; Cohen L; Löwik C; Papapoulos S
Biochem Biophys Res Commun; 1999 Oct; 264(1):108-11. PubMed ID: 10527849
[TBL] [Abstract][Full Text] [Related]
8. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.
Fisher JE; Rodan GA; Reszka AA
Endocrinology; 2000 Dec; 141(12):4793-6. PubMed ID: 11108295
[TBL] [Abstract][Full Text] [Related]
9. Common musculoskeletal adverse effects of oral treatment with once weekly alendronate and risedronate in patients with osteoporosis and ways for their prevention.
Bock O; Boerst H; Thomasius FE; Degner C; Stephan-Oelkers M; Valentine SM; Felsenberg D
J Musculoskelet Neuronal Interact; 2007; 7(2):144-8. PubMed ID: 17627083
[TBL] [Abstract][Full Text] [Related]
10. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.
Jauhiainen M; Mönkkönen H; Räikkönen J; Mönkkönen J; Auriola S
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2967-75. PubMed ID: 19665949
[TBL] [Abstract][Full Text] [Related]
11. Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis.
Teng KH; Liang PH
Bioorg Chem; 2012 Aug; 43():51-7. PubMed ID: 21993493
[TBL] [Abstract][Full Text] [Related]
12. Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation.
Lutz RJ; McLain TM; Sinensky M
J Biol Chem; 1992 Apr; 267(12):7983-6. PubMed ID: 1569056
[TBL] [Abstract][Full Text] [Related]
13. Different reaction mechanisms for cis- and trans-prenyltransferases.
Lu YP; Liu HG; Liang PH
Biochem Biophys Res Commun; 2009 Feb; 379(2):351-5. PubMed ID: 19103164
[TBL] [Abstract][Full Text] [Related]
14. Purification of geranylgeranyl diphosphate synthase from bovine brain.
Sagami H; Morita Y; Korenaga T; Ogura K
Acta Biochim Pol; 1994; 41(3):293-302. PubMed ID: 7856400
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid-induced IPP/ApppI production in vivo.
Mönkkönen H; Ottewell PD; Kuokkanen J; Mönkkönen J; Auriola S; Holen I
Life Sci; 2007 Sep; 81(13):1066-70. PubMed ID: 17850825
[TBL] [Abstract][Full Text] [Related]
16. Short-chain prenyl diphosphate synthase that condenses isopentenyl diphosphate with dimethylallyl diphosphate in ispA null Escherichia coli strain lacking farnesyl diphosphate synthase.
Saito K; Fujisaki S; Nishino T
J Biosci Bioeng; 2007 Jun; 103(6):575-7. PubMed ID: 17630132
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of (S)-isoprenoid thiodiphosphates as substrates and inhibitors.
Phan RM; Poulter CD
J Org Chem; 2001 Oct; 66(20):6705-10. PubMed ID: 11578224
[TBL] [Abstract][Full Text] [Related]
18. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase.
Grove JE; Brown RJ; Watts DJ
J Bone Miner Res; 2000 May; 15(5):971-81. PubMed ID: 10804029
[TBL] [Abstract][Full Text] [Related]
19. Decaprenyl pyrophosphate synthetase from mitochondria of pig liver.
Ishii K; Sagami H; Ogura K
Biochem Biophys Res Commun; 1983 Oct; 116(2):500-6. PubMed ID: 6651825
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and application of a fluorescent substrate analogue to study ligand interactions for undecaprenyl pyrophosphate synthase.
Chen AP; Chen YH; Liu HP; Li YC; Chen CT; Liang PH
J Am Chem Soc; 2002 Dec; 124(51):15217-24. PubMed ID: 12487597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
